Shannon Wiley focuses her practice on healthcare regulatory and transactional matters with a specific emphasis on the pharmaceutical industry specializing in specialty pharmacy, digital pharmacy, infusion providers, and digital pharmacy. Shannon provides clients with legal guidance driven by a deep understanding of their business. She assists clients with transactional and regulatory matters involving ambulatory infusion centers, management relationships for health system pharmacies and infusion practices, digital pharmacy networks, limited distribution networks, pharmacy services agreements, the 340B program and associated contract pharmacy relationships, hub arrangements, data services arrangements, and GPO agreements. She advises clients on regulations such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, FDA regulations such as the Drug Supply Chain Security Act and state pharmacy laws.
American Health Law Association (AHLA)
National Association of Specialty Pharmacies (NASP)
American Pharmacists Association (APhA)
National Infusion Center Association (NICA)
Representation of Providence Ventures in a $20 million investment in TailorMed Medical, a leading financial navigation software platform. Providence Ventures led the financing round and was joined by new investors UnityPoint Health Ventures, Almeda Ventures, Bridges Israel and Discount Capital with participation from existing investors Accelmed, Sanara Ventures and Triventures.
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
Representation of Kinderhook Industries, LLC in its investment in AbsoluteCARE, value-based primary care provided headquartered in Baltimore, Maryland, for $105 million. Kinderhook Industries, LLC is a private investment firm that manages over $3.3 billion of committed capital.
Representation of Linden Capital Partners, a Chicago-based healthcare private equity firm, as healthcare regulatory counsel in its acquisition of UroGPO from Nautic Partners. UroGPO is a urology-specific Group Purchasing Organization and provider of educational programs for providers.
Representation of the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible for the operational and strategic management of Chartwell to CarepathRx, a platform company formed by Nautic Partners that offers pharmacy solutions to patients undergoing complicated medication therapies. Nautic will manage the UPMC pharmacy moving forward. Terms of the transaction were not disclosed.
Representation of OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care, in its sale to Amerita, Inc., a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. Terms of the transaction were not disclosed.
Representation of J. Knipper and Company, Inc. – one of the largest suppliers of end-to-end pharmaceutical samples management services and a Court Square portfolio company – and its affiliates, including KnippeRx, in its acquisition of Eagle Pharmacy – a Florida-based full-service, direct-to-patient (DTP) pharmacy. This strategic transaction for KnippeRx will expand the company’s pharmacy programs, scale and automation capabilities.
Representation of Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor of home infusion services. Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry
Representation of PipelineRx, a developer of a cloud-based pharmacy platform intended to optimize and transform pharmacy and amplify its impact on patient care, as regulatory and deal counsel in its sale to CarepathRx, a platform company formed by Nautic Partners that offers pharmacy solutions to patients undergoing complicated medication therapies
Leadership Council on Legal Diversity (LCLD) — Fellow (2020)
Mid-South Super Lawyers “Rising Star” (2013-2020)
Cecil C. Humphreys Law Review